BDTX icon

Black Diamond Therapeutics

86 hedge funds and large institutions have $64.1M invested in Black Diamond Therapeutics in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 26 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
-8
Holders Change %
-8.51%
% of All Funds
1.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
22
Reduced
26
Closed
19
Calls
$3K
Puts
$192K
Net Calls
-$189K
Net Calls Change
-$16K
Name Holding Trade Value Shares
Change
Shares
Change %
Jane Street
76
Jane Street
New York
-$202K -37,866 Closed
MAM
77
Martingale Asset Management
Massachusetts
-$197K -36,920 Closed
Nomura Holdings
78
Nomura Holdings
Japan
-$189K -35,061 Closed
TI
79
Trexquant Investment
Connecticut
-$186K -34,809 Closed
Walleye Capital
80
Walleye Capital
New York
-$145K -27,131 Closed
Jacobs Levy Equity Management
81
Jacobs Levy Equity Management
New Jersey
-$132K -24,754 Closed
VF
82
Virtu Financial
New York
-$121K -22,664 Closed
Squarepoint
83
Squarepoint
New York
-$100K -18,674 Closed
PCM
84
Prelude Capital Management
New York
-$61K -11,483 Closed
ProShare Advisors
85
ProShare Advisors
Maryland
-$53K -10,082 Closed
Walleye Trading
86
Walleye Trading
New York
-$53K -10,000 Closed
QT
87
Quantbot Technologies
New York
-$34K -6,500 Closed
Koshinski Asset Management
88
Koshinski Asset Management
Illinois
-$2.13K -400 Closed
CA
89
CoreCap Advisors
Michigan
-$1K -120 Closed